CANF

Can-Fite BioPharma

12 hedge funds and large institutions have $1.52M invested in Can-Fite BioPharma in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$264K
2 +$59.4K
3 +$5.03K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$3.11K

Top Sellers

1 -$34.5K
2 -$27K
3 -$27K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.31M
2
$102K
3
$59.4K
4
$34.1K
5
$6.03K
6
$5.03K
7
$1.21K
8
$1.11K
9
$402
10
$372
11
$38
12
13